8-K
filed June 2, 2026, 8:30 AM ET
ticker IVF
CIK 0001417926
other material
confidence high
sentiment negative
materiality 0.75
INVO Fertility restates 2025 Q1-Q3 financials; non-reliance due to accounting errors
INVO Fertility, Inc.
- Non-reliance on unaudited 10-Qs for Q1-Q3 2025 due to errors in derivative, debt extinguishment, and preferred stock classification.
- Errors do not impact revenue or operations; limited to asset, liability, equity, and net income line items.
- Restatement to be included in the 2025 Form 10-K; historical amounts will be recast in future filings.
- Audit committee and management discussed the issues with independent auditor WithumSmith+Brown, PC.
Featured in Daily 8-K Digest
Machine-readable event card
- schema_version
- secwatch.filing_event.v1
- accession
- 0001493152-26-026772
- form_type
- 8-K
- ticker
- IVF
- cik
- 0001417926
- company_name
- INVO Fertility, Inc.
- filed_at
- 2026-06-02T12:30:27+00:00
- discovered_at
- 2026-06-02T12:35:28.335431+00:00
- generated_at
- 2026-06-02T12:36:47.404027+00:00
- sec_items
- ["4.02", "9.01"]
- event_type
- other_material
- sentiment
- negative
- materiality_score
- 0.75
- calibrated_materiality_score
- 0.75
- confidence
- high
- secwatch_canonical_url
- https://secwatch.observer/filing/0001493152-26-026772
- json_url
- https://secwatch.observer/filing/0001493152-26-026772.json
- markdown_url
- https://secwatch.observer/filing/0001493152-26-026772.md
- text_url
- https://secwatch.observer/filing/0001493152-26-026772.txt
- edgar_index_url
- https://www.sec.gov/Archives/edgar/data/1417926/000149315226026772/0001493152-26-026772-index.htm
- edgar_primary_document_url
- https://www.sec.gov/Archives/edgar/data/1417926/000149315226026772/form8-k.htm
- generated_by_model
- deepseek-v4-flash:cloud@v2
- review_status
- machine_generated
- human_reviewed
- false
- corrected
- false
- correction_note
- null
- correction_timestamp
- null
- superseded_by
- null
Comparable filings
RITE
MineralRite restates financials, cuts asset carrying value from $432M to $246M
MINERALRITE Corp
May 27, 2026, 4:02 PM ET
other_material
Items 4.02, 7.01, 8.01, 9.01
same fact type: auditor_change
same SEC item: 4.02, 9.01
same event type: other_material
similar materiality
This filing
On June 1, 2026, the audit committee of the Company, after considering the recommendations of management, concluded that the Company’s previously issued unaudited consolidated financial statements contained within its (i) Quarterly Report on Form 10-Q as of March 31, 2025 and for the three months then ended, filed with the Securities and Exchange Commission (“SEC”) on May 20, 2025, (ii) Quarterly Report on Form 10-Q as of June 30, 2025 and for the three and six months then ended, filed with the SEC on August 14, 2025, and (iii) Quarterly Report on Form 10-Q as of September 30, 2025 and for the three and nine months then ended, filed with the SEC on November 17, 2025 should no longer be relied due the 2025 Financial Statement Errors.
Comparable filing
management determined that certain previously issued financial statements contained in the Company’s previously filed Annual Report on Form 10 for the fiscal year ended December 31, 2025, and Quarterly Report on Form 10-Q for the quarter ended March 31, 2026, should no longer be relied upon.
Filing page
SEC filing
NMTC
NeuroOne restates Q1 FY2026 results due to revenue recognition error; reaffirms FY2026 guidance
NEUROONE MEDICAL TECHNOLOGIES Corp
May 22, 2026, 4:30 PM ET
other_material
Items 4.02, 7.01, 9.01
same fact type: auditor_change
same SEC item: 4.02, 9.01
same event type: other_material
similar materiality
This filing
On June 1, 2026, the audit committee of the Company, after considering the recommendations of management, concluded that the Company’s previously issued unaudited consolidated financial statements contained within its (i) Quarterly Report on Form 10-Q as of March 31, 2025 and for the three months then ended, filed with the Securities and Exchange Commission (“SEC”) on May 20, 2025, (ii) Quarterly Report on Form 10-Q as of June 30, 2025 and for the three and six months then ended, filed with the SEC on August 14, 2025, and (iii) Quarterly Report on Form 10-Q as of September 30, 2025 and for the three and nine months then ended, filed with the SEC on November 17, 2025 should no longer be relied due the 2025 Financial Statement Errors.
Comparable filing
On May 21, 2026, the Audit Committee (the “Audit Committee”) of the Board of Directors of NeuroOne Medical Technologies Corporation (the “Company”), after discussion with management, determined that the Company’s previously issued interim financial statements included in the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2026, filed on May 12, 2026 (the “Previous Filing”), should no longer be relied upon and should be restated because of accounting errors relating to revenue recognition.
Filing page
SEC filing
CGC
Canopy Growth restates FY2024-2025 financials due to warrant classification error; Q4/FY2026 results delayed to June 15
Canopy Growth Corp
May 15, 2026, 5:06 PM ET
other_material
Items 4.02, 7.01, 9.01
same fact type: auditor_change
same SEC item: 4.02, 9.01
same event type: other_material
similar materiality
This filing
On June 1, 2026, the audit committee of the Company, after considering the recommendations of management, concluded that the Company’s previously issued unaudited consolidated financial statements contained within its (i) Quarterly Report on Form 10-Q as of March 31, 2025 and for the three months then ended, filed with the Securities and Exchange Commission (“SEC”) on May 20, 2025, (ii) Quarterly Report on Form 10-Q as of June 30, 2025 and for the three and six months then ended, filed with the SEC on August 14, 2025, and (iii) Quarterly Report on Form 10-Q as of September 30, 2025 and for the three and nine months then ended, filed with the SEC on November 17, 2025 should no longer be relied due the 2025 Financial Statement Errors.
Comparable filing
the audit committee of the board of directors of the Company (the “Audit Committee”) was made aware of and, after discussion with senior management of the Company, concluded that the Company’s previously issued (i) audited consolidated financial statements for the fiscal year ended March 31, 2024, included in the Company’s Annual Report on Form 10-K for such fiscal year (the “2024 10-K”), (ii) audited consolidated financial statements for the fiscal year ended March 31, 2025, included in the Company’s Annual Report on Form 10-K for such fiscal year (the “2025 10-K”) and (iii) unaudited consolidated financial statements for the quarterly periods ended September 30, 2023, December 31, 2023, June 30, 2024, September 30, 2024, December 31, 2024, June 30, 2025, September 30, 2025, and December 31, 2025, included in the Company’s Quarterly Reports on Form 10-Q for such quarterly periods (collectively, the “Prior Financial Statements”), should no longer be relied upon
Filing page
SEC filing
PREAXIA HEALTH CARE PAYMENT SYSTEMS INC.
PreAxia restates Aug 31, 2025 financials; stock award errors, material weakness
PREAXIA HEALTH CARE PAYMENT SYSTEMS INC.
April 21, 2026, 7:59 PM ET
other_material
Items 4.02, 9.01
same fact type: auditor_change
same SEC item: 4.02, 9.01
same event type: other_material
similar materiality
This filing
On June 1, 2026, the audit committee of the Company, after considering the recommendations of management, concluded that the Company’s previously issued unaudited consolidated financial statements contained within its (i) Quarterly Report on Form 10-Q as of March 31, 2025 and for the three months then ended, filed with the Securities and Exchange Commission (“SEC”) on May 20, 2025, (ii) Quarterly Report on Form 10-Q as of June 30, 2025 and for the three and six months then ended, filed with the SEC on August 14, 2025, and (iii) Quarterly Report on Form 10-Q as of September 30, 2025 and for the three and nine months then ended, filed with the SEC on November 17, 2025 should no longer be relied due the 2025 Financial Statement Errors.
Comparable filing
On April 9, 2026, the management of PreAxia Health care Payment Systems Inc., a Nevada corporation (the “Company”), identified material errors in the previously released financial statements for the three months ended August 31, 2025 (the “Non-Reliance Period”) and concluded that such financial statements should no longer be relied upon.
Filing page
SEC filing
CNTY
Century Casinos dismisses Grant Thornton, appoints EY as new auditor; cites material weaknesses
CENTURY CASINOS INC /CO/
May 28, 2026, 4:11 PM ET
other_material
Items 4.01, 9.01
same fact type: auditor_change
same SEC item: 9.01
same event type: other_material
similar materiality
This filing
On June 1, 2026, the audit committee of the Company, after considering the recommendations of management, concluded that the Company’s previously issued unaudited consolidated financial statements contained within its (i) Quarterly Report on Form 10-Q as of March 31, 2025 and for the three months then ended, filed with the Securities and Exchange Commission (“SEC”) on May 20, 2025, (ii) Quarterly Report on Form 10-Q as of June 30, 2025 and for the three and six months then ended, filed with the SEC on August 14, 2025, and (iii) Quarterly Report on Form 10-Q as of September 30, 2025 and for the three and nine months then ended, filed with the SEC on November 17, 2025 should no longer be relied due the 2025 Financial Statement Errors.
Comparable filing
(b) Engagement of Independent Registered Public Accounting Firm On May 22, 2026, the Audit Committee appointed Ernst & Young LLP (“EY”) as our independent registered public accounting firm to audit our consolidated financial statements for the fiscal year ending December 31, 2026.
Filing page
SEC filing
ALUR
Allurion Technologies dismisses Deloitte & Touche, appoints CBIZ; discloses material weaknesses
ALLURION TECHNOLOGIES, INC.
May 27, 2026, 4:35 PM ET
other_material
Items 4.01, 9.01
same fact type: auditor_change
same SEC item: 9.01
same event type: other_material
similar materiality
This filing
On June 1, 2026, the audit committee of the Company, after considering the recommendations of management, concluded that the Company’s previously issued unaudited consolidated financial statements contained within its (i) Quarterly Report on Form 10-Q as of March 31, 2025 and for the three months then ended, filed with the Securities and Exchange Commission (“SEC”) on May 20, 2025, (ii) Quarterly Report on Form 10-Q as of June 30, 2025 and for the three and six months then ended, filed with the SEC on August 14, 2025, and (iii) Quarterly Report on Form 10-Q as of September 30, 2025 and for the three and nine months then ended, filed with the SEC on November 17, 2025 should no longer be relied due the 2025 Financial Statement Errors.
Comparable filing
On May 22, 2026 (the “Effective Date”), Deloitte was dismissed as our independent registered public accounting firm.
Filing page
SEC filing
WAST
Waste Energy Corp. files 8-K/A: auditor Integrität resigned amid disagreement over AZ litigation legal confirmations
WASTE ENERGY CORP.
May 27, 2026, 4:33 PM ET
other_material
Items 4.01, 9.01
same fact type: auditor_change
same SEC item: 9.01
same event type: other_material
similar materiality
This filing
On June 1, 2026, the audit committee of the Company, after considering the recommendations of management, concluded that the Company’s previously issued unaudited consolidated financial statements contained within its (i) Quarterly Report on Form 10-Q as of March 31, 2025 and for the three months then ended, filed with the Securities and Exchange Commission (“SEC”) on May 20, 2025, (ii) Quarterly Report on Form 10-Q as of June 30, 2025 and for the three and six months then ended, filed with the SEC on August 14, 2025, and (iii) Quarterly Report on Form 10-Q as of September 30, 2025 and for the three and nine months then ended, filed with the SEC on November 17, 2025 should no longer be relied due the 2025 Financial Statement Errors.
Comparable filing
ments contained in Integrität’s correspondence. Except as expressly
set forth herein, this Amendment does not amend, update, or change any other items or disclosures contained in the Original Report.
Filing page
SEC filing
OCTV
Octave Intelligence completes spin-off from Hexagon; draws $625M credit facility, changes auditor
Octave Intelligence plc
May 26, 2026, 6:02 AM ET
other_material
Items 1.01, 2.03, 4.01, 5.02, 8.01, 9.01
same fact type: auditor_change
same SEC item: 9.01
same event type: other_material
similar materiality
This filing
On June 1, 2026, the audit committee of the Company, after considering the recommendations of management, concluded that the Company’s previously issued unaudited consolidated financial statements contained within its (i) Quarterly Report on Form 10-Q as of March 31, 2025 and for the three months then ended, filed with the Securities and Exchange Commission (“SEC”) on May 20, 2025, (ii) Quarterly Report on Form 10-Q as of June 30, 2025 and for the three and six months then ended, filed with the SEC on August 14, 2025, and (iii) Quarterly Report on Form 10-Q as of September 30, 2025 and for the three and nine months then ended, filed with the SEC on November 17, 2025 should no longer be relied due the 2025 Financial Statement Errors.
Comparable filing
On May 20, 2026, the Audit Committee of the Board of Directors of the Company (i) dismissed PricewaterhouseCoopers AB (“PwC Sweden”) as the Company’s independent registered public accounting firm (the “Dismissal”) and (ii) appointed PricewaterhouseCoopers LLP, United States (“PwC US”) as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026 (the “Appointment”).
Filing page
SEC filing
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.